Previous 10 | Next 10 |
Shares of Aspira Women's Health Inc. (NASDAQ:AWH) traded today at $54.46, eclipsing its 52-week high. So far today approximately 31.9 million shares have been exchanged, as compared to an average 30-day volume of 433,000 shares. In the past 52 weeks, shares of Aspira Women's Health Inc. ...
Image source: The Motley Fool. Aspira Women's Health Inc. (NASDAQ: AWH) Q4 2021 Earnings Call Mar 23, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Aspira Women's Health Inc. (AWH) Q4 2021 Earnings Call Transcript...
Aspira Women's Health Inc. (AWH) Q4 2021 Results Conference Call March 23, 2022 08:30 AM ET Company Participants Valerie Palmieri - Executive Chair of the Board Nicole Sanford - President and Chief Executive Officer Rob Beechey - Chief Financial Officer Conference Call Participants Ross Osbor...
Aspira Women’s Health press release (NASDAQ:AWH): Q4 GAAP EPS of -$0.08 beats by $0.01. Revenue of $1.85M (+27.6% Y/Y) misses by $0.05M. Shares -1.89% PM. For further details see: Aspira Women’s Health GAAP EPS of -$0.08 beats by $0.01, revenue of $1.85M misses by $0.05M ...
Total Revenue Increased 46% to $6.8 million; OVA1 Volume Grew 28% to 17,359 Units Exercise of option in the Harvard Dana-Farber Cancer Institute Collaboration Leadership and Board appointments implemented in First Quarter of 2022 Conference Call and Webcast sched...
AUSTIN, Texas, March 15, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that the company will report its financial results for the year ended December 31, 2021 before the market open on Wednesda...
AUSTIN, Texas, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of Celeste Fralick, Ph.D., to its Board of Directors, effective February 23, 2022. Dr. Fralick is an a...
Aspira Women’s Health (NASDAQ:AWH) appointed Nicole Sandford as President and CEO and Valerie Palmieri as Executive Chair of the Board; Valerie served as CEO for eight years. A seasoned professional with 30+ years of experience in leading businesses as an innov...
AUSTIN, Texas, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today named Valerie Palmieri as Executive Chair of the Board, and Nicole Sandford as President and CEO of the Company. Jim LaFrance, Aspira&...
AUSTIN, Texas, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of Mr. Michael Newton as Head of Sales and Marketing who brings to the company over twenty years of experie...
News, Short Squeeze, Breakout and More Instantly...
Aspira Women's Health Inc. Company Name:
AWH Stock Symbol:
NASDAQ Market:
Aspira Women's Health Inc. Website:
Preliminary OvaWatch ® volume during Q2 2024 grew 24% over the prior quarter to 1,307 units Preliminary OvaSuite SM volume during Q2 2024 grew 11% over the prior quarter to 6,471 units AUSTIN, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Heal...
AUSTIN, Texas, July 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that i...
AUSTIN, Texas, July 01, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced it has...